JESUS G BERDEJA M.D. NPI 1902842412

NPI Details

Jesus G Berdeja, M.D. is a hematology and oncology internal medicine in Nashville, TN with 31 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. Jesus G Berdeja, M.D. NPI is 1902842412. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

The provider's business location address is:

250 25TH AVE N
STE 412
NASHVILLE, TN
ZIP 37203-632
Phone: (615) 986-7000
Fax: (615) 986-7601

The NPI 1902842412 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, daratumumab, 10 mg and hyaluronidase-fihj (HCPCS:J9144)
• Injection, filgrastim (g-csf), excludes biosimilars, 1 microgram (HCPCS:J1442)
• Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg (HCPCS:J1568)
• Gammaglobulin (immune system protein) measurement (HCPCS:82784)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Measurement of immunoglobulin light chains (HCPCS:83521)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Lactate dehydrogenase (enzyme) level (HCPCS:83615)
• Protein measurement, serum (HCPCS:84165)
• Immunologic analysis technique on serum (immunofixation) (HCPCS:86334)
• Magnesium level (HCPCS:83735)
• Phosphate level (HCPCS:84100)
• Uric acid level, blood (HCPCS:84550)
• Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
• Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
• Cyclophosphamide, 100 mg (HCPCS:J9070)
• Bilirubin level, direct (HCPCS:82248)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
• Injection, zoledronic acid, 1 mg (HCPCS:J3489)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
• Measurement of substance using immunoassay technique (HCPCS:83520)
• Beta-2 microglobulin (protein) level (HCPCS:82232)
• Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a (HCPCS:G9678)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional (HCPCS:99211)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Administration of pneumococcal vaccine (HCPCS:G0009)
• Total protein level, blood (HCPCS:84155)
• Infusion into a vein for hydration, each additional hour (HCPCS:96361)
• Ferritin (blood protein) level (HCPCS:82728)
• Administration of vaccine, each additional vaccine (HCPCS:90472)
• Pneumococcal vaccine, 13-valent (HCPCS:90670)
• Injection, fludarabine phosphate, 50 mg (HCPCS:J9185)
• Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
• Administration of vaccine (HCPCS:90471)
• Hepatitis b vaccine, adult dosage (3 dose schedule) (HCPCS:90746)
• Administration of hepatitis b vaccine (HCPCS:G0010)
• Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
• Iron level (HCPCS:83540)
• Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
• Infusion, normal saline solution, sterile (500 ml = 1 unit) (HCPCS:J7040)
• Hospital discharge day management, more than 30 minutes (HCPCS:99239)
• Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Administration of influenza virus vaccine (HCPCS:G0008)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
• Thyroid hormone, t3 measurement, free (HCPCS:84481)
• Thyroxine (thyroid chemical), free (HCPCS:84439)
• Iron binding capacity (HCPCS:83550)
• Vitamin d-3 level (HCPCS:82306)
• Pneumococcal vaccine, 23-valent (HCPCS:90732)
• Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage (HCPCS:90694)
• Blood test, lipids (cholesterol and triglycerides) (HCPCS:80061)
• New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)

The enumeration date for this NPI number is 6/22/2006 and was last updated on 1/25/2012.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.